老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

51.71
-1.6800-3.15%
成交量：81.55万
成交额：4,242.62万
市值：50.00亿
市盈率：-10.86
高：53.20
开：52.91
低：51.40
收：53.39
52周最高：78.00
52周最低：44.12
股本：9,669.26万
流通股本：9,316.62万
量比：0.40
换手率：0.88%
股息：- -
股息率：- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率：-26.09%
总资产收益率：-14.20%
市净率：2.86
市盈率(LYR):-7.99

数据加载中...

总览公司新闻资讯公告
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/14

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/29

重要事件披露

8-K - Current report
2021/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/02

重要事件披露

8-K - Current report
2021/04/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/27

重要事件披露

8-K - Current report
2021/04/20

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
更多